Pembrolizumab in Treating Minimal Residual Disease in Patients With Acute Lymphoblastic Leukemia
about
Pembrolizumab in Treating Minimal Residual Disease in Patients With Acute Lymphoblastic Leukemia
description
clinical trial
@en
klinisch onderzoek
@nl
name
Pembrolizumab in Treating Mini ...... h Acute Lymphoblastic Leukemia
@en
type
label
Pembrolizumab in Treating Mini ...... h Acute Lymphoblastic Leukemia
@en
prefLabel
Pembrolizumab in Treating Mini ...... h Acute Lymphoblastic Leukemia
@en
P1476
A Phase II Study of Anti-PD-1 ...... h Acute Lymphoblastic Leukemia
@en
P3098
NCT02767934
P4844
P580
2017-01-13T00:00:00Z
P582
2021-01-01T00:00:00Z